Drugs / ASN001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02349139 | Jan 2015 → Jul 2017 | castration-resistant prostate carcinoma | Asana BioSciences | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASN001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02349139 ↗ |
| Action | Inhibit | “Androgen inhibitor” NCT02349139 ↗ |